Nuveen’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-487,815
| Closed | -$41.4M | – | 3320 |
|
|
2019
Q4 | $41.4M | Sell |
487,815
-15,027
| -3% | -$1M | 0.02% | 766 |
|
|
2019
Q3 | $25.1M | Buy |
502,842
+49,145
| +11% | +$1.96M | 0.01% | 1010 |
|
|
2019
Q2 | $16.5M | Buy |
+453,697
| New | +$14.8M | 0.01% | 1271 |
|
|
2017
Q1 | – | Sell |
-271,883
| Closed | -$9.23M | – | 1530 |
|
|
2016
Q4 | $9.23M | Sell |
271,883
-51,288
| -16% | -$1.82M | 0.05% | 480 |
|
|
2016
Q3 | $12.2M | Sell |
323,171
-9,699
| -3% | -$366K | 0.07% | 331 |
|
|
2016
Q2 | $11.2M | Buy |
332,870
+80,233
| +32% | +$2.83M | 0.07% | 332 |
|
|
2016
Q1 | $8.03K | Sell |
252,637
-21,579
| -8% | -$705K | 0.04% | 381 |
|
|
2015
Q4 | $10.2K | Buy |
274,216
+31,104
| +13% | +$1.18M | 0.05% | 330 |
|
|
2015
Q3 | $9.23K | Buy |
+243,112
| New | +$8.53M | 0.05% | 348 |
|
|
2014
Q1 | – | Sell |
-5,272
| Closed | -$204K | – | 1638 |
|
|
2013
Q4 | $204K | Buy |
+5,272
| New | +$189K | ﹤0.01% | 1485 |
|
Other funds holding MDCO
Nuveen's MDCO Position: Q1 2020 in Review
Nuveen sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 487,815 shares — an estimated $41.4M sold.
Nuveen first reported a position in MDCO in Q4 2013 and held it in 10 quarters. The position peaked at $41.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Nuveen reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Nuveen sold 487,815 Medicines Co shares in Q1 2020, an estimated $41.4M.
- Nuveen first reported a position in Medicines Co in Q4 2013 and held it in 10 quarters.
- Nuveen's Medicines Co position peaked at $41.4M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Nuveen's 13F filing for Q1 2020, filed 14 May 2020.